Status:
TERMINATED
Study of Amiodarone Given Before Lung Surgery to Prevent Atrial Fibrillation After Lung Resection
Lead Sponsor:
Beth Israel Deaconess Medical Center
Conditions:
Atrial Fibrillation
Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Atrial fibrillation is a very common complication of pulmonary resection. Patients who develop atrial fibrillation require additional treatment and are more likely to stay in the hospital for longer p...
Detailed Description
Atrial fibrillation is a very common complication of pulmonary resection. Patients who develop atrial fibrillation require additional treatment and are more likely to stay in the hospital for longer p...
Eligibility Criteria
Inclusion
- Resectable lung nodule or mass
Exclusion
- Allergy to amiodarone
- Currently taking amiodarone
- Documented atrial fibrillation within past 12 months
- Known pulmonary fibrosis
- Known hepatic dysfunction
- Thyroid disease
- 2nd or 3rd degree heart block
- Severe SA node disease
- Bradycardia-induced syncope
- Pregnancy
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 13 2009
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT00300495
Start Date
February 1 2006
End Date
October 13 2009
Last Update
April 28 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215